
Forest Laboratories is restructuring and shedding jobs in a bid to save $500 million in costs by the end of …
The 3 Monkeys Communications firm has been chosen to run a new psoriasis brief for Forest Laboratories. The brief is …
NICE has given final recommendation to two new inhalers for cystic fibrosis (CF) patients.Forest Lab’s Colobreath (colistimethate sodium) and Novartis’ …
Claris reports visual acuity gains with experimental LSCD treatment
Amphista doses first patient in AML trial of protein degrader
Jennings becomes President of Beckman Coulter Diagnostics

